|Articles|October 28, 2019
Shifting The Paradigm for Retinal Disease Management
Advertisement
Trouble viewing this PDF?
If you are unable to download this pdf file, please try again in another browser.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
2
Ocular Therapeutix accelerates NDA submission plans for AXPAXLI for wet AMD
3
Study maps thermal dynamics of glaucoma laser treatments
4
FDA grants IDE approval to EyeYon Medical for its US clinical study of EndoArt
5










































.png)


